|
FKBP1AP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.717690E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.264500E-02 |
| Normal-vs-Stage2 |
5.621200E-01 |
| Normal-vs-Stage3 |
3.603900E-03 |
| Normal-vs-Stage4 |
8.637700E-03 |
| Stage1-vs-Stage2 |
3.042600E-01 |
| Stage1-vs-Stage3 |
1.351980E-01 |
| Stage1-vs-Stage4 |
1.486760E-01 |
| Stage2-vs-Stage3 |
8.178100E-02 |
| Stage2-vs-Stage4 |
9.173800E-02 |
| Stage3-vs-Stage4 |
9.831000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.543900E-03 |
| Normal-vs-AfricanAmerican |
1.166290E-02 |
| Normal-vs-Asian |
4.541200E-01 |
| Caucasian-vs-AfricanAmerican |
3.556200E-01 |
| Caucasian-vs-Asian |
1.91762999999234E-05 |
| AfricanAmerican-vs-Asian |
5.764800E-04 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.417530E-02 |
| Normal-vs-Female |
3.822100E-02 |
| Male-vs-Female |
3.300400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.137900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.944200E-02 |
| Normal-vs-Age(61-80Yrs) |
4.396500E-02 |
| Normal-vs-Age(81-100Yrs) |
5.084800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.742200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.773000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.392600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.996800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.742800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.514400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.110580E-01 |
| Classical-VS-Follicular |
3.562100E-02 |
| Classical-VS-Other |
6.684800E-01 |
| Classical-VS-Normal |
9.479000E-03 |
| Tall-VS-Follicular |
5.081500E-03 |
| Tall-VS-Other |
8.014800E-01 |
| Tall-VS-Normal |
1.361160E-03 |
| Follicular-VS-Other |
3.604400E-01 |
| Follicular-VS-Normal |
6.806000E-01 |
| Other-VS-Normal |
1.699560E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.298100E-02 |
| Normal-vs-N1 |
6.515200E-03 |
| N0-vs-N1 |
1.701410E-01 |
|
|
